House Report Spotlights Drug Company Stock Buybacks, High Salaries
WASHINGTON — Pharmaceutical companies spend lavishly on stock buybacks and executive salaries even as Americans struggle to pay for their high-cost prescription drugs, Democratic House members said. “For too long, Big Pharma has charged patients in this country exorbitant prices for critically needed drugs,” said Rep. Carolyn Maloney (D-N.Y.), chairwoman of the House Oversight and […]